Question

Difficulty: HardDiagnostic Testing Performance

A specialized hepatology referral center is evaluating a novel non-invasive serum biomarker panel to identify advanced hepatic fibrosis in patients with metabolic dysfunction-associated steatohepatitis. The baseline prevalence of advanced fibrosis in this specific clinic population is 40%40\%. The manufacturer's documentation includes a receiver operating characteristic (ROC) curve for the assay.

To align with 2026 consensus guidelines aimed at minimizing the risk of missing patients who require urgent hepatocellular carcinoma screening and intervention, the clinic's quality improvement committee decides to shift the positive diagnostic cutoff value from point X (sensitivity 75%75\%, specificity 95%95\%) to point Y (sensitivity 95%95\%, specificity 75%75\%).

Assuming the patient population and disease prevalence remain identical, which of the following statements most accurately describes the expected statistical impact of this cutoff adjustment?

  1. A
    The positive predictive value will increase, and the negative likelihood ratio will decrease.
  2. B
    The false discovery rate will decrease, and the area under the receiver operating characteristic curve will remain unchanged.
  3. The negative predictive value will increase, and the area under the receiver operating characteristic curve will remain unchanged.Answer
  4. D
    The negative predictive value will increase, and the positive predictive value will remain unchanged.
  5. E
    Both the negative predictive value and the area under the receiver operating characteristic curve will increase.

Answer

The negative predictive value will increase, and the area under the receiver operating characteristic curve will remain unchanged.
The correct answer accurately states that the negative predictive value (NPV) will increase while the area under the receiver operating characteristic (ROC) curve remains unchanged. By shifting the diagnostic cutoff from point X to point Y, the clinic is intentionally lowering the threshold for a positive result to maximize sensitivity (increasing from 75%75\% to 95%95\%). This drastically decreases the number of false negatives, meaning that a negative test result becomes much more reliable for ruling out advanced fibrosis; thus, the NPV increases. Furthermore, the ROC curve is a graphical representation of the test's intrinsic performance across all possible cutoff values. Selecting a different clinical threshold simply moves the operating point along the existing curve but does not change the total area under the ROC curve (AUC), which reflects the overall diagnostic utility of the test regardless of the chosen threshold.

Step-by-Step Solution

1
Analyze the clinical goal of the cutoff shift from point X to point Y.
The clinic wants to minimize false negatives (missed advanced fibrosis), so they choose a cutoff with higher sensitivity (95%95\%) at the expense of specificity (75%75\%).
A highly sensitive test is required to reliably rule out the disease (SnNout).
2
Determine the mathematical effect of this shift on predictive values.
Because sensitivity increases (fewer false negatives), the Negative Predictive Value (NPV) increases. Conversely, because specificity decreases (more false positives), the Positive Predictive Value (PPV) decreases.
Even with a constant disease prevalence, predictive values fluctuate when the intrinsic test parameters (sensitivity and specificity) are altered by a threshold change.
3
Assess the impact of the cutoff shift on the ROC curve.
The area under the curve (AUC) remains completely unchanged.
The ROC curve plots sensitivity against 1-specificity for all possible cutoffs. Changing the specific clinical cutoff merely moves the operating point along this fixed curve; it does not alter the curve itself.

Key Concept

Effect of diagnostic cutoff adjustments on predictive values and intrinsic test properties.
Rate this question